Ipm. Tomlinson et al., LOSS OF HETEROZYGOSITY IN MALIGNANT-MELANOMA AT LOCI ON CHROMOSOME-11AND CHROMOSOME-17 IMPLICATED IN THE PATHOGENESIS OF OTHER CANCERS, Genes, chromosomes & cancer, 7(3), 1993, pp. 169-172
Forty-six cases of sporadic melanoma have been investigated for loss o
f heterozygosity at 4 loci: D11S29 (11q23), YNZ22 (17p13.3), TP53 (17p
l3.1); and NM23 (17q22). Each of the loci is thought to be important i
n the pathogenesis of other tumours. Mutations were found infrequently
at the YNZ22, NM23, and TPS3 loci. At D11S29, however, the frequency
of mutation in the melanoma samples was high (67%) and mutations at th
is locus were associated with younger age at presentation. This region
of chromosome 11 is also commonly mutated in breast cancers and haema
tological malignancies. Genetic aberrations at D11S29 may therefore re
present nonspecific mutations found in several malignancies or part of
a pathway common to the malignant phenotype. (C) 1993 Wiley-Liss, Inc
.